Clinical Trial

Liver Embolization Approaches for Tumor Management

Study acronym: LEATUM
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors. The main aim is to evaluate progression free survival following embolization in this study population or evaluate residual hepatic volume in cases in which these techniques are used to induce liver regeneration. This study is an observational registry - all patients will follow their normal therapeutic and treatment scheme as per clinical practice, without any additional intervention.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-02-03.
Trial Details
NCT Number NCT05714124
Lead Sponsor IRCCS San Raffaele
Conditions Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer, Metastatic Cancer, Metastatic Gastric Cancer, Primary Liver Cancer, Metastatic Pancreatic Cancer
Enrollment 580 participants
Start Date 2021-05-21
Primary Completion 2026-12-31 (estimated)
Study Completion 2031-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-04-12